GIS vs IRMD · P/E 8.2, rev $4.61B vs P/E 51, rev $42.4M
General Mills Inc (GIS) versus Iradimed Co (IRMD) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Iradimed Co (IRMD) is a medical devices company listed on US.
Latest reported GIS revenue for 2026-05-31 was $4.61B. Net income was -$2.01B. Revenue was up 1.2% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Not investment advice. Open the GIS and IRMD stock pages for the full models.
Not investment advice.